Viral-associated hemophagocytic syndrome (VAHS)
Showing 1 - 25 of >10,000
Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,
Hemophagocytic Syndrome, T/NK-Cell Lymphoma Trial in Zhengzhou (Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine,
Recruiting
- Hemophagocytic Syndrome
- T/NK-Cell Lymphoma
- Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
-
Zhengzhou, Henan, ChinaOncology Department of The First Affiliated Hospital of Zhengzho
Aug 3, 2021
COVID-19-Associated Encephalitis, Multisystem Inflammatory Syndrome in Children Trial in Taipei (delineate its prognostic
Recruiting
- COVID-19-Associated Encephalitis
- Multisystem Inflammatory Syndrome in Children
- delineate its prognostic biomarker, host genetic factors, immunopathogenesis and viral pathogenesis
-
Taipei, Chung Cheng District, TaiwanNational Taiwan University Hospital
Oct 12, 2022
COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction, COVID-19-Associated Thromboembolism Trial in Chongqing
Active, not recruiting
- COVID-19 Stress Syndrome
- +5 more
- Atorvastatin Calcium Tablets
-
Chongqing, Chongqing, ChinaResidential Address
May 1, 2023
HLH Trial in Beijing (Thiotepa)
Recruiting
- HLH
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 10, 2023
Covid19, ARDS, Pneumonia, Viral Trial in United States (DB-001, Intravenous normal saline)
Completed
- Covid19
- +2 more
- DB-001
- Intravenous normal saline
-
Sheffield, Alabama
- +4 more
Jan 13, 2022
EBV Infection Trial in Suzhou (PD-1 mAb)
Recruiting
- EBV Infection
- PD-1 monoclonal antibody
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Sep 1, 2021
Associated Burden of Related Conditions in Alopecia Areata
Completed
- Alopecia Areata
- +35 more
- Exposure of interest (studies 2 & 3).
-
London, United KingdomMomentum Data Ltd
Dec 13, 2022
Prognosis and Therapeutic Decision Tool for Autoimmunity and
Not yet recruiting
- Autoimmune Lymphoproliferative Syndrome
- +19 more
- Collection of samples
- (no location specified)
May 26, 2021
EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)
Recruiting
- EBV-associated Hemophagocytic Lymphohistiocytosis
- EBV Infection
- EBV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 12, 2023
Prospective Validation of the OHI Index
Recruiting
- HLH
- +4 more
-
Kfar Saba, Israel
- +1 more
May 21, 2023
Immune Function and PD-1 Antibody Therapy Efficacy Predictors on
Recruiting
- Secondary Hemophagocytic Lymphohistiocytosis
- Chronic Active Epstein-Barr Virus Infection
- No intervention
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 2, 2023
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Children and Adult Hemophagocytic Syndrome (HLHa)
Completed
- Hemophagocytic Syndrome
- Identification of biological markers
-
Paris, FranceClinical Research Unit
Nov 19, 2021
Lymphoma-associated Hemophagocytic Lymphohistiocytosis
Recruiting
- Lymphoma
- Hemophagocytic Lymphohistiocytoses
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 1, 2023
Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)
Recruiting
- Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
-
Innsbruck, Austria
- +9 more
Oct 24, 2022
PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)
Not yet recruiting
- PD-1 Antibody
- +3 more
- L-DEP and PD-1 antibody
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 8, 2023
Adult Hemophagocytic Lymphohistiocytosis in Critically Ill
Recruiting
- Hemophagocytic Lymphohistiocytosis
-
Berlin, GermanyDepartment of Anesthesiology and Operative Intensive Care Medici
Jul 13, 2021
Hemophagocytic Lymphohistiocytoses, Lymphoma Trial in Beijing (cytokine)
Not yet recruiting
- Hemophagocytic Lymphohistiocytoses
- Lymphoma
- cytokine
-
Beijing, Beijing, ChinaZhao Wang
Oct 27, 2022
Cytokine Storm, COVID-19 Trial in Birmingham (Anakinra, Normal saline)
Active, not recruiting
- Cytokine Storm
- COVID-19
- Anakinra
- Normal saline
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 23, 2023
Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)
Not yet recruiting
- Hemophagocytic Lymphohistiocytoses
- +2 more
- observational
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Dec 22, 2022
Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)
Not yet recruiting
- Carbapenem Resistant Bacterial Infection
- Hemophagocytic Lymphohistiocytoses
- Carrimycin tablets
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Aug 4, 2023
COVID-19, Acute Respiratory Distress Syndrome, Virus; Pneumonia Trial in Beijing (CAStem)
Unknown status
- COVID-19
- +3 more
- CAStem
-
Beijing, Beijing, China, ChinaBeijing YouAn Hospital, Capital Medical University
Mar 31, 2020
Covid19, SARS-CoV Infection Trial in United States (Metformin, Placebo, Fluvoxamine)
Active, not recruiting
- Covid19
- SARS-CoV Infection
- Metformin
- +3 more
-
Sylmar, California
- +6 more
Aug 5, 2022